Abbas, Y. et al. 2024. Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis. AL-Kindy College Medical Journal. 20, 3 (Dec. 2024), 216–221. DOI:https://doi.org/10.47723/2km3dk27.